JLE

Médecine de la Reproduction

MENU

Uterus transplantation in human Volume 15, issue 2, Avril-Mai-Juin 2013

Figures

See all figures

Authors
Service de Gynécologie-Obstétrique, Hopital Mère-Enfant, CHU Dupuytren, av Larrey 87000 Limoges, Pharmacologie, Toxicologie et Pharmacovigilance, INSERM, UMR-S850, CHU Dupuytren, 87000 Limoges, Coordination hospitalière des prélèvements, CHU Dupuytren, 87000 Limoges, Service Anatomo-Pathologie, CHU Dupuytren, 87000 Limoges, Service Immunologie, secteur HLA, CHU Dupuytren, 87000 Limoges, Service Chirurgie Vasculaire et Transplantation, CHU Dupuytren, 87000 Limoges, Service Néphrologie, CHU Dupuytren, 87000 Limoges

Except adoption, absolute uterine factor infertility lacks solution in case of motherhood desire. Gestational surrogacy is still not approved in France. Over the last decade, uterus transplantation experimentation made advances. Data from animal research, progress in immunosuppressive treatment and knowledge about pregnancy after transplantation provide a scenario in which a human allo-transplantation project can become reality.